Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study

Aim: Thymosin alpha 1 (Tα1) is a promising treatment for the improvement of sepsis patients. Until now, its function in reducing acute organ damage of sepsis patients is still unclear. The aim of this study was to determine whether Tα1 can alleviate organ dysfunction in sepsis patients. Methods: Th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group
Format: Artigo
Jezik:Inglês
Izdano: Open Exploration Publishing Inc. 2022-04-01
Serija:Exploration of Immunology
Teme:
immunoparalysis
immunotherapy
thymosin alpha 1
sepsis
sequential organ failure assessment score
Online pristup:https://www.explorationpub.com/Journals/ei/Article/100345
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items